• Contact us
  • Investor Login
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
  • Team
  • Media
  • PAI Community
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
  • Team
  • Media
  • PAI Community
  • Contact us
  • Investor Login
  • All
    media
  • PAI publications
  • Press releases
  • Videos
  • 19 Jan 2017

    Ethypharm acquires Martindale Pharma in the UK

    Martindale Pharma is a leading UK-based specialty pharmaceutical company providing essential medicines to over 50 countries around the world. The company specializes in the field of opioid addiction, emergency care and sterile injectables.
    Read more 2541
  • 19 Jan 2017

    Ethypharm acquires Martindale Pharma in the UK

    Martindale Pharma is a leading UK-based specialty pharmaceutical company providing essential medicines to over 50 countries around the world. The company specializes in the field of opioid addiction, emergency care and sterile injectables.
    Read more 2541
  • 01 Dec 2016

    PAI Partners and Goldman Sachs agree sale of the Xella Group to Lone Star

    Read more 1590
  • 11 Aug 2016

    Roompot Vakanties to be sold to PAI Partners

    The acquisition will enable Roompot to further grow its position as the largest provider of quality recreational accommodations in the Netherlands and accelerate the implementation of its development plan.
    Read more 2075
  • 09 Jun 2016

    PAI Partners has signed an agreement to acquire Ethypharm

    Ethypharm is a leading European specialty pharma focusing on growing end-markets such as the treatment of pain and addictions. With a presence in France, Germany, the UK, Canada, the US and China, Ethypharm generates over €200 million in sales.
    Read more 385
  • 30 May 2016

    PAI Partners enters into an agreement to purchase Atos Medical

    Atos Medical develops, manufactures and sells a range of products that help patients who have undergone total laryngectomy to restore their ability to speak and increase their quality of life.
    Read more 384
  • 27 Apr 2016

    Nestlé and R&R to create Froneri, an ice cream and frozen food joint venture

    The new company will combine Nestlé and R&R’s ice cream activities in the relevant countries and will include Nestlé’s European frozen food business (excluding pizza and retail frozen food in Italy), as well as its chilled dairy business in the Philippines.
    Read more 386
  • 27 Apr 2016

    Financière Gaillon 8 S.A. announces the successful sale of part of its stake in Kaufman & Broad at 31.50 euros per share

    Read more 388
  • 26 Feb 2016

    PAI Partners and ADB Airfield Solutions to acquire Safegate from Fairford Group

    Through this combination between PAI-owned ADB and Safegate, we are creating the world leader in advanced airfield guidance systems, from aircraft landing to parking.
    Read more 389
  • 15 Dec 2015

    The Carlyle Group and Montefiore Investment announce they have entered into exclusive negotiations with PAI Partners for the sale of B&B Hotels

    Read more 390
  • 14 Dec 2015

    PAI Partners enters into exclusive discussions to sell GCS to RPC

    GCS has been transformed under PAI's ownership into an efficient group repositioned towards value-added closures and dispensing products in selected markets.
    Read more 391
1‒34567‒9

Press enquiries

Matthieu Roussellier
Head of Communications
PAI Partners
+44 20 7297 4674
Greenbrook Communications
James Madsen
Fanni Bodri
+44 20 7952 2000
DGM Conseil
Hugues Schmitt
Quentin Hua
+33 1 40 70 11 89

Follow us

Follow us on social media for regular updates and to join the conversation

This website uses cookies to improve user's experience.

For more information about how we use cookies, how to manage them or block/delete them please refer to our Cookie Policy.

Back to top
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
  • Investments
    • Business Services
    • Food & Consumer
    • General Industrials
    • Healthcare
    • Retail & Distribution
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
  • Team
    • Capital Markets Team
    • Communications Team
    • Compliance Team
    • Country Teams
    • ESG Team
    • Finance Team
    • HR Team
    • Investment Group
    • Investor Team
    • Mid-Market Fund Team
    • PAI Performance Group
    • Sector Teams
  • Media
    • PAI publications
    • Press releases
    • Videos
  • PAI Community
© PAI 2021. | PAI Partners 2019 | PAI Partners SAS: Registered in France No. 443 837 331. PAI Partners SAS is a fund management company approved and regulated by the AMF in France (approval number GP-06000052). PAI Partners S.à r.l. : Registered in Luxembourg No. B136689. PAI Partners S.à r.l. is a fund management company approved and regulated by the CSSF in Luxembourg (approval number N. A00000625).   PAI and PAI Partners are registered trademarks.  
  • Contact us
  • Terms & Conditions
  • Legal disclaimer
  • Cookie Policy
  • Privacy notice
  • Accessibility
  • Investor Login